Who Paid My Doc
IRESSA US Clinical Access Program CAP
Research payments
$187,141
Through program year 2024, $187,141 in research payments was reported against IRESSA US Clinical Access Program CAP, across 52 payments, paid by AstraZeneca Pharmaceuticals LP.
- Paid by
- AstraZeneca Pharmaceuticals LP
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $38,469 | 4 |
| 2023 | Research | $63,100 | 7 |
| 2022 | Research | $33,660 | 9 |
| 2021 | Research | $7,590 | 5 |
| 2020 | Research | $22,442 | 12 |
| 2019 | Research | $21,880 | 15 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Renwick Goldberg Myrtle Beach, SC Named on 5 payments
- Ira Gore Birmingham, AL Named on 4 payments
- Steven Mccune Marietta, GA Named on 2 payments
- Daniel Schneider Helena, MT Named on 2 payments
- Timothy Cloughesy Los Angeles, CA Named on 2 payments
- Ronald Natale West Hollywood, CA Named on 2 payments
- Ramaswamy Govindan Saint Louis, MO Named on 2 payments
- Jack Jacoub Fountain Valley, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.